| Detected | Trial | Change |
|---|---|---|
| 2026-06-10 | NCT07039760 Asciminib With or Without Sildenafil for Brain Tumors |
date change Primary completion pushed: 2027-10-31 -> 2028-02-28 |
| 2026-06-10 | NCT07039760 Asciminib With or Without Sildenafil for Brain Tumors |
date change Completion pushed: 2027-11-30 -> 2028-03-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT07391579 | Daily Tadalafil 5 mg Combined With On-Demand Sildenafil 100 mg for Treatment of Erectile… | Erectile Dysfunctions | Recruiting |
| Phase 3 | |||
| NCT06123156 | Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and… | Rectal Cancer | Recruiting |
| Phase 2/3 | |||
| NCT07462260 | Sildinafil in Pulmonary Hypertension-Rheumatic Chronic Valvular Disease(RCT) | Pulmonary Hypertension | Recruiting |
| NCT06800092 | Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment | Cancer | Not Yet Recruiting |
| Phase 2 | |||
| NCT06954597 | Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic… | Digital Ulcers in Systemic Sclerosis | Recruiting |
| NCT05061368 | Oral Sildenafil for Exercise Capacity, Dyspnea and Cardiopulmonary Function in COPD | Chronic Obstructive Pulmonary Disease | Recruiting |
| NCT06810284 | Sildenafil Plus Hypothermia to Treat Neonatal Encephalopathy | Hypoxic-Ischemic Encephalopathy | Not Yet Recruiting |
| Phase 1 | |||
| NCT06324396 | IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated… | Fontan Circulation | Recruiting |
| Early Phase 1 | |||
| NCT06510322 | Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support | Vascular Diseases | Recruiting |
| NCT07039760 | Asciminib With or Without Sildenafil for Brain Tumors | Brain Tumor | Not Yet Recruiting |